Sol-Gel to Present at Upcoming Healthcare Investor Conferences in September
September 08 2020 - 7:05AM
Sol-Gel Technologies (NASDAQ: SLGL), (“Sol-Gel”), a clinical-stage
dermatology company focused on identifying, developing and
commercializing branded and generic topical drug products for the
treatment of skin diseases, today announced that the company
will present at the following upcoming virtual investor
conferences.
Dr. Alon Seri-Levy, Sol-Gel’s Chief Executive
Officer, will provide an overview of the Company and give a
business update. A live webcast of the presentation will be
available under the “Events and Presentations” in the investors
section of the Company’s website at www.sol-gel.com. An archived
webcast recording of the event will be available on the website for
approximately 30 days.
H.C. Wainwright Healthcare
Conference |
|
|
|
Speaker: |
|
Gilad Mamlok, Chief Financial Officer |
Date: |
|
September 15, 2020 |
Time: |
|
10:00 AM ET |
|
|
|
Cantor Fitzgerald Virtual Global Healthcare
Conference – Fireside Chat |
|
|
|
Speakers: |
|
Dr. Alon Seri-Levy, Chief Executive Officer |
|
|
Gilad Mamlok, Chief Financial Officer |
|
|
John Vieira, U.S. Head of Commercialization |
Date: |
|
September 17, 2020 |
Time: |
|
8:40 AM ET |
About Sol-Gel TechnologiesSol-Gel is a
clinical-stage dermatology company focused on identifying,
developing and commercializing branded and generic topical drug
products for the treatment of skin
diseases. Sol-Gel leverages its proprietary
microencapsulation technology platform for Twyneo, for the
treatment of acne vulgaris, and Epsolay, for the treatment of
papulopustular rosacea. The Company’s pipeline also includes
SGT-210, an early-stage topical epidermal growth factor receptor
inhibitor, erlotinib, for the treatment of
punctate palmoplantar keratoderma, and preclinical assets
tapinarof and roflumilast. For additional information, please
visit www.sol-gel.com.
For further information, please contact:Sol-Gel
Contact:Gilad MamlokChief Financial Officer+972-8-9313433
Investor Contact:Lee SternSolebury Trout
+1-917-312-5998lstern@soleburytrout.com
Source: Sol-Gel Technologies Ltd.
Sol Gel Technologies (NASDAQ:SLGL)
Historical Stock Chart
From Aug 2024 to Sep 2024
Sol Gel Technologies (NASDAQ:SLGL)
Historical Stock Chart
From Sep 2023 to Sep 2024